Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

ABT MDT SYK ISRG Market Neutral Education Restaurants Small Value 
Benchmark SP 500  1,650   1.74  Index Moved Down -0.11% United States ...


Processing
Collecting data for MASI

Masimo quote and profile

 
 Companies |  Insiders  | Dashboard  
     
22.16
  
STOCK
(0.34)  Macroaxis: -1.51 Down   1.51%  
Year To Date
18.225.35
Last 1 Month(s)
21.3322.5
June 19 2013 

Diversification Suggestion

Use Masimo to protect against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly
Analyze Masimo Trend or Check current 30 days Masimo correlation with market (S&P 500)
1 Month Beta 1.0  
Highest Price:  
Lowest Price:  
22.5  
21.33  
June 18 2013 
June 05 2013 
Masimo returns are very sensitive to returns on the market. As market goes up or down, Masimo is expected to follow.
Masimo Corporation llmost one BetaMasimo Beta Legend
MASI United States Nasdaq
Masimo Corporation
Healthcare
Medical Appliances and Equipment
Benchmark S&P 500
http://www.masimo.com
Contact Number: 949. 297. 7000
Currency: USD - US Dollar
Traded on NASDAQ
    
Current Valuation1.14 B
Shares Outstanding56.62 M
Number of Shares Shorted4.63 M
Revenue508.15 M
 United States NYSE   0.14 % Macroaxis: 0.14 Moved Down  
 
 United States SP 500   0.41 % Macroaxis: 0.41 Moved Down  
 
 United States Russel   0.58 % Macroaxis: 0.58 Moved Down  
 
 thisRed MASI MASI agains markets  1.51 % Macroaxis: change 1.51 Moved Down  
 
Compare to Competition Alpha & Beta   Get Advice

Masimo Leadership

Joe Kiani Founder, Chairman and CEO
Anand Sampath Executive Vice President - Engineering
Jon Coleman President of Worldwide Sales and Marketing and Clinical Research and Sales and Marketing Professional, MBA
Rick Fishel President of Worldwide Oem Bus. and Corporate Devel.

Masimo Price and Market Media

The median price of Masimo for the period between Mon, May 20, 2013 and Wed, Jun 19, 2013 is 21.86 with a coefficient of variation of 1.23. The daily time series for the period is distributed with a sample standard deviation of 0.27, arithmetic mean of 21.86, and mean deviation of 0.2. The Stock received substential amount of media coverage during this period.
Masimo         SP 500
Price Growth (%)
 
Change Benchmark  Embed  Export  Timeline
1
MASIMO CORPORATION Study Shows Noninvasive SpCO Can Help Rap...05/22/2013Macroaxis: News
2
MASIMO CORPORATION El Paso Children Hospital Standardizes to...05/24/2013Macroaxis: News
3
MASIMO CORPORATION University Children Hospital Basel Instal...06/07/2013Macroaxis: News
4
MASIMO CORPORATION Masimo Signs FarReaching Pulse Oximetry ....06/12/2013Macroaxis: News
5
Henry Schein and Masimo Ink New Deal Analyst Blog06/14/2013Macroaxis: News

Masimo Summary

Masimo Corporation [MASI] is traded on NASDAQ in USA. It is located in Irvine, CA and employs 2,866 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.21 B. Masimo Corporation conducts business under Healthcare sector and is part of Medical Appliances and Equipment industry. This company has 56.62 M outstanding shares of which 4.63 M shares are now shorted by private and institutional investors with about 15.4 trading days to cover.
Masimo Corporationration, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring solutions worldwide. more
Past Market
Over 30
Days
3
Out Of
100
 
Chance of
Less
Than
%
 
Follow Masimo with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Masimo to your reader
 

Masimo Research Report

Masimo vs. Abbott

Correlation analysis and fundamentals comparison between Masimo and Abbott Laboratories

Masimo Executives

Mark Raad CFO, Principal Accounting Officer, Executive VP and Corporate Secretary
Anthony Allan COO

Masimo Directors

Jack Lasersohn Independent Director
Steven Barker Independent Director
Edward Cahill Independent Director
Sanford Fitch Independent Director, MBA
Robert Coleman Independent Director, Ph.D

Masimo Management

Yongsam Lee Executive VP of Operations and CIO
Sheree Aronson Investor Relations Officer

Masimo Fundamentals

Cash per Share vs Shares Owned by Institutions
Price to Book vs Price to Earnings To Growth
Cash per Share vs Cash Flow from Operations
Short Ratio vs Price to Earnings To Growth

Masimo vs Competition

Masimo vs. Abbott Laboratories
Masimo vs. Boston Scientific Corporation
Masimo vs. Smith Nephew plc
Masimo vs. Edwards Lifesciences Corp

Masimo June 19 2013 Opportunity Range

Downside Deviation1.33
Information Ratio0.0951
Maximum Drawdown4.17
Value At Risk(2.08)
Potential Upside1.57

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium